Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...
This year’s job market has taken a hit across industries, as higher retail costs led to weaker consumer demand and concerns ...
Rejecting a Trump request in a 6-3 decision, the court on Tuesday left in force a judge’s ruling that has blocked the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results